Loading viewer...
conference
Format: PDF conference
MorphoSys announced its acquisition of Constellation Pharmaceuticals with strategic funding partnership support from Royalty Pharma plc. The transaction includes advancement of Constellation's clinical pipeline including pelabresib and other candidates. Call details executive presentations on R&D integration and financial strategy.
investor_presentation
25 Pages
conference
30 Pages
IDEXX Laboratories
Camden National Corporation 2016 Piper Jaffray Conference
conferenceconference
28 Pages
Camden National Corporation
SS&C Technologies 2022 Needham Virtual Growth Conference
conferenceconference
23 Pages
SS&C Technologies Holdings, Inc.